Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machaon Bonafede

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Journal of Medical Economics|March 3, 2023
Healthcare resource utilization and costs of care in the United States for patients with non-alcoholic steatohepatitisElliot B Tapper, Machaon Bonafede, Jesse Fishman, et al.
Open Forum Infectious Diseases|July 27, 2023
Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18-64 Years During the 2019-2020 US Influenza SeasonMahrukh Imran, Juan Puig-Barbera, Justin R Ortiz, et al.
Pulmonary Therapy|April 29, 2021
Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United StatesTeja Thorat, Lisa J McGarry, Krutika Jariwala-Parikh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2017
Real-World Economic Burden Associated with Transplantation-Related ComplicationsMiguel-Angel Perales, Machaon Bonafede, Qian Cai, et al.
The American Journal of Managed Care|April 19, 2018
Cost sharing and branded antidepressant initiation among patients treated with genericsJason D Buxbaum, Michael E Chernew, Machaon Bonafede, et al.
Journal of Comparative Effectiveness Research|October 6, 2025
Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitisElliot B Tapper, Taylor Ryan, Ni Zeng, et al.
Vaccines|May 26, 2026
Incidence of COVID-19 and Influenza-Related Outcomes and Vaccinations in the United States, October 2022 Through December 2024Heather R Hensler, Tianyi Lu, Yoonyoung Park, et al.
BMC Endocrine Disorders|May 1, 2024
Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology RegistryJay P Bae, Lee Kallenbach, David R Nelson, et al.
Journal of Managed Care & Specialty Pharmacy|December 12, 2019
Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on EtanerceptMachaon Bonafede, Hafiz Oko-Osi, Mahdi Gharaibeh, et al.
Leukemia & Lymphoma|April 10, 2020
The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapyJoseph Tkacz, Jacob Garcia, Mathew Gitlin, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Journal of Medical Economics|March 3, 2023
Healthcare resource utilization and costs of care in the United States for patients with non-alcoholic steatohepatitisElliot B Tapper, Machaon Bonafede, Jesse Fishman, et al.
Open Forum Infectious Diseases|July 27, 2023
Relative Effectiveness of the Cell-Based Quadrivalent Influenza Vaccine in Preventing Cardiorespiratory Hospitalizations in Adults Aged 18-64 Years During the 2019-2020 US Influenza SeasonMahrukh Imran, Juan Puig-Barbera, Justin R Ortiz, et al.
Pulmonary Therapy|April 29, 2021
Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United StatesTeja Thorat, Lisa J McGarry, Krutika Jariwala-Parikh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 10, 2017
Real-World Economic Burden Associated with Transplantation-Related ComplicationsMiguel-Angel Perales, Machaon Bonafede, Qian Cai, et al.
The American Journal of Managed Care|April 19, 2018
Cost sharing and branded antidepressant initiation among patients treated with genericsJason D Buxbaum, Michael E Chernew, Machaon Bonafede, et al.
Journal of Comparative Effectiveness Research|October 6, 2025
Healthcare costs and treatment patterns associated with glucagon-like peptide 1 receptor agonist use among patients with metabolic dysfunction-associated steatohepatitisElliot B Tapper, Taylor Ryan, Ni Zeng, et al.
Vaccines|May 26, 2026
Incidence of COVID-19 and Influenza-Related Outcomes and Vaccinations in the United States, October 2022 Through December 2024Heather R Hensler, Tianyi Lu, Yoonyoung Park, et al.
BMC Endocrine Disorders|May 1, 2024
Obesity and metabolic syndrome in patients with heart failure with preserved ejection fraction: a cross-sectional analysis of the Veradigm Cardiology RegistryJay P Bae, Lee Kallenbach, David R Nelson, et al.
Journal of Managed Care & Specialty Pharmacy|December 12, 2019
Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on EtanerceptMachaon Bonafede, Hafiz Oko-Osi, Mahdi Gharaibeh, et al.
Leukemia & Lymphoma|April 10, 2020
The economic burden to payers of patients with diffuse large B-cell lymphoma during the treatment period by line of therapyJoseph Tkacz, Jacob Garcia, Mathew Gitlin, et al.
Pageof 10